Specifically, Rb1 and Rg1 treatment improved PPARγ expression and decreased total cholesterol, triglyceride, and glucose levels in peripheral blood of patients with type 2 diabetes [18]. The gene discussed is PPP1R3A; the disease is type 2 diabetes mellitus.